Sun Pharmaceutical Industries has announced the launch of FEXUCLUE, a novel potassium-competitive acid blocker (P-CAB), in India.
Sun Pharmaceutical Industries has launched Fexuprazan tablets 40 mg in India under the brand name FEXUCLUE. FEXUCLUE, a novel potassium competitive acid blocker (PCAB), is approved as a new treatment ...
Cullen Frost Bankers Inc. decreased its holdings in Amazon.com, Inc. (NASDAQ:AMZN) by 0.6% in the fourth quarter, Holdings ...
Tony’s Chocolonely has recalled two of its Easter eggs as they may contain pieces of metal. The recall impacts specific ...
Kercheville Advisors LLC lifted its holdings in shares of Apple Inc. (NASDAQ:AAPL – Free Report) by 3.3% during the fourth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results